Interestingly, in patients with end stage renal disease (ESRD), the risk of death and cardiovascular events was additionally increased when both—levels of ADMA and mediators of inflammation (C-reactive protein (CRP) or IL-6) in plasma—were elevated compared to patients with elevation of only one biomarker [71]. This evidence concerns the gene CRP and chronic kidney disease.